NVE Corporation Reports Third Quarter Results and Announces Quarterly Dividend
NVE (NVEC) reported financial results for Q3 fiscal 2025. Total revenue decreased 25% to $5.06 million compared to $6.76 million in the prior-year quarter, attributed to a 22% decline in product sales and a 74% drop in contract research and development revenue.
Net income fell 27% to $3.05 million, or $0.63 per diluted share, versus $4.18 million ($0.87 per share) in the prior-year quarter. For the first nine months of fiscal 2025, total revenue decreased 18% to $18.6 million, while net income declined 16% to $11.2 million ($2.31 per diluted share).
The company declared a quarterly dividend of $1.00 per share, payable February 28, 2025, to shareholders of record as of February 3, 2025.
NVE (NVEC) ha riportato i risultati finanziari per il terzo trimestre dell'anno fiscale 2025. Le entrate totali sono diminuite del 25% a 5,06 milioni di dollari rispetto ai 6,76 milioni di dollari dello stesso trimestre dell'anno precedente, a causa di una diminuzione del 22% nelle vendite di prodotti e di un calo del 74% nelle entrate da ricerca e sviluppo contrattuale.
Il reddito netto è sceso del 27% a 3,05 milioni di dollari, ovvero 0,63 dollari per azione diluita, rispetto ai 4,18 milioni di dollari (0,87 dollari per azione) dello stesso trimestre dell'anno precedente. Per i primi nove mesi dell'anno fiscale 2025, le entrate totali sono diminuite del 18% a 18,6 milioni di dollari, mentre il reddito netto è calato del 16% a 11,2 milioni di dollari (2,31 dollari per azione diluita).
L'azienda ha dichiarato un dividendo trimestrale di 1,00 dollaro per azione, che sarà pagato il 28 febbraio 2025, agli azionisti registrati al 3 febbraio 2025.
NVE (NVEC) reportó los resultados financieros para el tercer trimestre del año fiscal 2025. Los ingresos totales disminuyeron un 25% a 5.06 millones de dólares en comparación con 6.76 millones de dólares en el trimestre del año pasado, atribuido a una caída del 22% en las ventas de productos y una disminución del 74% en los ingresos por investigación y desarrollo bajo contrato.
Los ingresos netos cayeron un 27% a 3.05 millones de dólares, o 0.63 dólares por acción diluida, frente a 4.18 millones de dólares (0.87 dólares por acción) en el trimestre del año anterior. En los primeros nueve meses del año fiscal 2025, los ingresos totales disminuyeron un 18% a 18.6 millones de dólares, mientras que los ingresos netos se redujeron un 16% a 11.2 millones de dólares (2.31 dólares por acción diluida).
La compañía declaró un dividendo trimestral de 1.00 dólar por acción, que se pagará el 28 de febrero de 2025, a los accionistas registrados a partir del 3 de febrero de 2025.
NVE (NVEC)는 2025 회계연도 3분기 재무 실적을 보고했습니다. 총 수익은 전년 동기 대비 25% 감소한 506만 달러로 나타났으며, 이는 제품 판매의 22% 감소와 계약 연구 개발 수익의 74% 감소에 기인합니다.
순이익은 27% 감소하여 305만 달러, 즉 희석 주당 0.63달러로 줄어들었으며, 이는 전년 동기 418만 달러(주당 0.87달러)와 비교됩니다. 2025 회계연도 첫 9개월 동안 총 수익은 18.6백만 달러로 18% 감소했으며, 순이익은 16% 감소한 1120만 달러(희석 주당 2.31달러)로 줄어들었습니다.
회사는 주당 1.00달러의 분기 배당금을 발표했으며, 2025년 2월 28일에 기록된 주주에게 지급될 예정입니다. 기록 기준일은 2025년 2월 3일입니다.
NVE (NVEC) a rapporté les résultats financiers pour le troisième trimestre de l'exercice 2025. Les revenus totaux ont diminué de 25 % pour atteindre 5,06 millions de dollars par rapport à 6,76 millions de dollars au trimestre de l'année précédente, en raison d'une baisse de 22 % des ventes de produits et d'une chute de 74 % des revenus liés à la recherche et développement sous contrat.
Le bénéfice net a chuté de 27 % à 3,05 millions de dollars, soit 0,63 dollar par action diluée, contre 4,18 millions de dollars (0,87 dollar par action) au trimestre de l'année précédente. Pour les neuf premiers mois de l'exercice 2025, les revenus totaux ont diminué de 18 % pour atteindre 18,6 millions de dollars, tandis que le bénéfice net a baissé de 16 % à 11,2 millions de dollars (2,31 dollars par action diluée).
L'entreprise a déclaré un dividende trimestriel de 1,00 dollar par action, payable le 28 février 2025, aux actionnaires enregistrés au 3 février 2025.
NVE (NVEC) hat die finanziellen Ergebnisse für das dritte Quartal des Geschäftsjahres 2025 bekannt gegeben. Der Gesamtumsatz fiel um 25 % auf 5,06 Millionen Dollar im Vergleich zu 6,76 Millionen Dollar im Vorjahresquartal, was auf einen Rückgang der Produktverkäufe um 22 % und einen Rückgang der Einnahmen aus vertraglicher Forschung und Entwicklung um 74 % zurückzuführen ist.
Der Nettogewinn sank um 27 % auf 3,05 Millionen Dollar, also 0,63 Dollar pro verwässerter Aktie, im Vergleich zu 4,18 Millionen Dollar (0,87 Dollar pro Aktie) im Vorjahresquartal. In den ersten neun Monaten des Geschäftsjahres 2025 fiel der Gesamtumsatz um 18 % auf 18,6 Millionen Dollar, während der Nettogewinn um 16 % auf 11,2 Millionen Dollar (2,31 Dollar pro verwässerter Aktie) zurückging.
Das Unternehmen erklärte eine vierteljährliche Dividende von 1,00 Dollar pro Aktie, die am 28. Februar 2025 an die Aktionäre ausgezahlt wird, die am 3. Februar 2025 im Aktienbuch eingetragen sind.
- Maintained substantial quarterly dividend of $1.00 per share
- Remained profitable despite industry challenges with $3.05M quarterly net income
- 72% increase in contract research and development revenue for the nine-month period
- 25% decrease in quarterly revenue to $5.06M
- 27% decline in quarterly net income to $3.05M
- 22% decrease in product sales in Q3
- 74% drop in quarterly contract research and development revenue
- 18% decrease in nine-month revenue to $18.6M
Insights
NVE 's Q3 FY2025 results reveal substantial business headwinds, with revenue declining
The revenue mix shift is particularly noteworthy. The
The maintained
The spintronics technology sector is experiencing cyclical headwinds, typical in specialized semiconductor segments. NVE's performance should be viewed in the context of its niche market position and the broader industry slowdown. The company's ability to maintain high profit margins despite revenue pressure demonstrates strong operational efficiency and pricing power, though the declining top-line warrants close monitoring by investors.
Total revenue for the third quarter of fiscal 2025 decreased
For the first nine months of fiscal 2025, total revenue decreased
The company also announced a quarterly cash dividend to shareholders of
“We are pleased to report solid earnings for the quarter and first nine months of the fiscal year, despite challenging industry conditions,” said NVE President and Chief Executive Officer Daniel A. Baker, Ph.D.
NVE is a leader in the practical commercialization of spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. The company manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data.
Statements used in this press release that relate to future plans, events, financial results, or performance are forward-looking statements that are subject to certain risks and uncertainties including, among others, such factors as our reliance on several large customers for a significant percentage of revenue, uncertainties related to the economic environments in the industries we serve, uncertainties related to future sales and revenues, risks and uncertainties related to future dividend payments, as well as the risk factors listed from time to time in our filings with the SEC, including our Annual Report on Form 10-K for the fiscal year ended March 31, 2024.
NVE CORPORATION
|
||||||||
|
|
Quarter Ended December 31, |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
Revenue |
|
|
|
|
|
|
|
|
Product sales |
|
$ |
4,960,488 |
|
|
$ |
6,366,009 |
|
Contract research and development |
|
|
102,557 |
|
|
|
390,251 |
|
Total revenue |
|
|
5,063,045 |
|
|
|
6,756,260 |
|
Cost of sales |
|
|
797,622 |
|
|
|
1,355,067 |
|
Gross profit |
|
|
4,265,423 |
|
|
|
5,401,193 |
|
Expenses |
|
|
|
|
|
|
|
|
Research and development |
|
|
869,677 |
|
|
|
540,895 |
|
Selling, general, and administrative |
|
|
434,783 |
|
|
|
389,311 |
|
Total expenses |
|
|
1,304,460 |
|
|
|
930,206 |
|
Income from operations |
|
|
2,960,963 |
|
|
|
4,470,987 |
|
Interest income |
|
|
474,180 |
|
|
|
491,671 |
|
Other income |
|
|
135,057 |
|
|
|
- |
|
Income before taxes |
|
|
3,570,200 |
|
|
|
4,962,658 |
|
Provision for income taxes |
|
|
521,790 |
|
|
|
778,236 |
|
Net income |
|
$ |
3,048,410 |
|
|
$ |
4,184,422 |
|
Net income per share – basic |
|
$ |
0.63 |
|
|
$ |
0.87 |
|
Net income per share – diluted |
|
$ |
0.63 |
|
|
$ |
0.87 |
|
Cash dividends declared per common share |
|
$ |
1.00 |
|
|
$ |
1.00 |
|
Weighted average shares outstanding |
|
|
|
|
|
|
|
|
Basic |
|
|
4,835,262 |
|
|
|
4,833,401 |
|
Diluted |
|
|
4,839,124 |
|
|
|
4,837,230 |
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended December 31, |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
Revenue |
|
|
|
|
|
|
|
|
Product sales |
|
$ |
17,680,780 |
|
|
$ |
22,183,223 |
|
Contract research and development |
|
|
924,199 |
|
|
|
537,727 |
|
Total revenue |
|
|
18,604,979 |
|
|
|
22,720,950 |
|
Cost of sales |
|
|
2,720,370 |
|
|
|
5,034,556 |
|
Gross profit |
|
|
15,884,609 |
|
|
|
17,686,394 |
|
Expenses |
|
|
|
|
|
|
|
|
Research and development |
|
|
2,595,808 |
|
|
|
1,920,095 |
|
Selling, general, and administrative |
|
|
1,543,428 |
|
|
|
1,298,211 |
|
Provision for credit losses |
|
|
- |
|
|
|
9,514 |
|
Total expenses |
|
|
4,139,236 |
|
|
|
3,227,820 |
|
Income from operations |
|
|
11,745,373 |
|
|
|
14,458,574 |
|
Interest income |
|
|
1,432,568 |
|
|
|
1,440,289 |
|
Other income |
|
|
135,057 |
|
|
|
- |
|
Income before taxes |
|
|
13,312,998 |
|
|
|
15,898,863 |
|
Provision for income taxes |
|
|
2,140,856 |
|
|
|
2,587,145 |
|
Net income |
|
$ |
11,172,142 |
|
|
$ |
13,311,718 |
|
Net income per share – basic |
|
$ |
2.31 |
|
|
$ |
2.75 |
|
Net income per share – diluted |
|
$ |
2.31 |
|
|
$ |
2.75 |
|
Cash dividends declared per common share |
|
$ |
3.00 |
|
|
$ |
3.00 |
|
Weighted average shares outstanding |
|
|
|
|
|
|
|
|
Basic |
|
|
4,834,382 |
|
|
|
4,832,992 |
|
Diluted |
|
|
4,839,247 |
|
|
|
4,839,725 |
|
NVE CORPORATION
|
||||||||
|
|
(Unaudited)
December 31,
|
|
|
March 31,
|
|
||
ASSETS |
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
5,485,684 |
|
|
$ |
10,283,550 |
|
Marketable securities, short-term (amortized cost of |
|
|
14,907,252 |
|
|
|
11,917,779 |
|
Accounts receivable, net of allowance for credit losses of |
|
|
1,355,064 |
|
|
|
3,144,833 |
|
Inventories |
|
|
7,787,624 |
|
|
|
7,158,585 |
|
Prepaid expenses and other assets |
|
|
736,481 |
|
|
|
689,349 |
|
Total current assets |
|
|
30,272,105 |
|
|
|
33,194,096 |
|
Fixed assets |
|
|
|
|
|
|
|
|
Machinery and equipment |
|
|
11,663,886 |
|
|
|
10,501,096 |
|
Leasehold improvements |
|
|
1,956,309 |
|
|
|
1,956,309 |
|
|
|
|
13,620,195 |
|
|
|
12,457,405 |
|
Less accumulated depreciation and amortization |
|
|
11,645,199 |
|
|
|
11,403,383 |
|
Net fixed assets |
|
|
1,974,996 |
|
|
|
1,054,022 |
|
Deferred tax assets |
|
|
1,689,207 |
|
|
|
1,453,704 |
|
Marketable securities, long-term (amortized cost of |
|
|
29,704,367 |
|
|
|
30,788,301 |
|
Right-of-use asset – operating lease |
|
|
947,889 |
|
|
|
289,910 |
|
Total assets |
|
$ |
64,588,564 |
|
|
$ |
66,780,033 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
154,683 |
|
|
$ |
127,154 |
|
Accrued payroll and other |
|
|
511,589 |
|
|
|
729,215 |
|
Operating lease |
|
|
84,838 |
|
|
|
179,372 |
|
Total current liabilities |
|
|
751,110 |
|
|
|
1,035,741 |
|
Operating lease |
|
|
864,966 |
|
|
|
175,775 |
|
Total liabilities |
|
|
1,616,076 |
|
|
|
1,211,516 |
|
|
|
|
|
|
|
|
|
|
Shareholders’ equity |
|
|
|
|
|
|
|
|
Common stock |
|
|
48,372 |
|
|
|
48,337 |
|
Additional paid-in capital |
|
|
19,806,845 |
|
|
|
19,554,812 |
|
Accumulated other comprehensive loss |
|
|
(295,358 |
) |
|
|
(777,637 |
) |
Retained earnings |
|
|
43,412,629 |
|
|
|
46,743,005 |
|
Total shareholders’ equity |
|
|
62,972,488 |
|
|
|
65,568,517 |
|
Total liabilities and shareholders’ equity |
|
$ |
64,588,564 |
|
|
$ |
66,780,033 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20250122706985/en/
NVE Investor Relations
investor@nve.com
Source: NVE Corporation
FAQ
What was NVEC's revenue decrease in Q3 2025?
How much is NVEC's quarterly dividend payment for February 2025?
What was NVEC's earnings per share for Q3 2025?
How did NVEC's product sales perform in Q3 2025?